NasdaqCM - Delayed Quote USD

ProKidney Corp. (PROK)

Compare
1.6000
-0.0200
(-1.23%)
At close: January 29 at 4:00:01 PM EST
1.6000
0.00
(0.00%)
After hours: January 29 at 4:08:45 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
156,315.0000
151,522.0000
153,007.0000
55,110.0000
27,024.0000
Operating Income
-156,315.0000
-151,522.0000
-153,007.0000
-55,110.0000
-27,024.0000
Net Non Operating Interest Income Expense
20,230.0000
22,071.0000
5,768.0000
2.0000
43.0000
Pretax Income
-136,085.0000
-129,451.0000
-147,239.0000
-55,108.0000
-26,981.0000
Tax Provision
491.0000
5,996.0000
896.0000
38.0000
-232.0000
Net Income Common Stockholders
-45,609.0000
-35,468.0000
-108,032.0000
-55,146.0000
-26,749.0000
Diluted NI Available to Com Stockholders
-45,609.0000
-35,468.0000
-108,032.0000
-55,146.0000
-26,749.0000
Basic EPS
-0.54
-0.57
-0.23
-0.30
-0.14
Diluted EPS
-0.54
-0.57
-0.23
-0.30
-0.14
Basic Average Shares
81,403.9230
61,714.2250
61,540.2310
186,500.0000
186,500.0000
Diluted Average Shares
81,403.9230
61,714.2250
61,540.2310
186,500.0000
186,500.0000
Total Operating Income as Reported
-156,315.0000
-151,522.0000
-153,007.0000
-55,110.0000
-27,024.0000
Total Expenses
156,315.0000
151,522.0000
153,007.0000
55,110.0000
27,024.0000
Net Income from Continuing & Discontinued Operation
-45,609.0000
-35,468.0000
-108,032.0000
-55,146.0000
-26,749.0000
Normalized Income
-45,609.0000
-35,468.0000
-108,032.0000
-55,146.0000
-26,749.0000
Interest Income
20,240.0000
22,083.0000
5,983.0000
2.0000
43.0000
Interest Expense
10.0000
12.0000
215.0000
--
--
Net Interest Income
20,230.0000
22,071.0000
5,768.0000
2.0000
43.0000
EBIT
-136,075.0000
-129,439.0000
-147,024.0000
-55,108.0000
-26,981.0000
EBITDA
-131,071.0000
-125,586.0000
-143,988.0000
-53,124.0000
-26,017.0000
Reconciled Depreciation
5,004.0000
3,853.0000
3,036.0000
1,984.0000
964.0000
Net Income from Continuing Operation Net Minority Interest
-45,609.0000
-35,468.0000
-108,032.0000
-55,146.0000
-26,749.0000
Normalized EBITDA
-131,071.0000
-125,586.0000
-143,988.0000
-53,124.0000
-26,017.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0000
12/31/2020 - 6/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PASG Passage Bio, Inc.
0.5764
0.00%
 
PPBT Purple Biotech Ltd
3.3600
-1.47%
 
AVTE Aerovate Therapeutics, Inc.
2.5750
+4.67%
 
IMCR Immunocore Holdings plc
31.64
-1.37%
 
BOLD Boundless Bio, Inc.
2.4600
+0.82%
 
IKNA Ikena Oncology, Inc.
1.5000
+1.35%
 
TNGX Tango Therapeutics, Inc.
3.1100
-0.32%
 
PMVP PMV Pharmaceuticals, Inc.
1.4300
+1.42%
 
MTVA MetaVia Inc.
1.8900
-4.06%
 
DSGN Design Therapeutics, Inc.
4.9400
-1.40%